Relay Therapeutics Inc Sustainability Reports

Relay Therapeutics, Inc. operates as a clinical-stage precision medicine company. The company utilizes its Dynamo platform to discover and develop small molecule therapies for targeted oncology and genetic diseases.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

FIGI: BBG00DSS08L8

8 reports from 2020 to 2025

• Relay Therapeutics Inc 2025 Form 10-K
• Relay Therapeutics Inc 2024 Form 10-K
• Relay Therapeutics Inc 2023 Corporate Responsibility Report
• Relay Therapeutics Inc 2022 Environmental, Social and Governance Report
• Relay Therapeutics Inc 2021 Form 10-K